Lenzing Puts Assets on the Block as Cost Cuts and Fresh Capital Underwrite Its Overhaul

Lenzing is weighing the sale of unspecified assets while pressing ahead with a restructuring that will cost jobs, close plants and absorb a nine-figure writedown before any of the promised benefits reach the bottom line. The Austrian fibre maker confirmed on Thursday that it is reviewing disposal options for the assets in question, disclosing the move alongside nine-month figures that sent its shares up 6.2%.

The stock reaction had less to do with the top line than with what lies beneath it. Revenue for the first nine months of 2026 slipped to EUR 1.93 billion from EUR 1.97 billion a year earlier, yet adjusted EBITDA held almost flat at EUR 353 million. That lifted the adjusted EBITDA margin to 18.3% from 17.9%, a gain management can point to as evidence that day-to-day operations have steadied even as sales volumes retreat.

The Bill Behind the Stabilisation

Getting there has not been cheap. Restructuring charges of EUR 36.6 million pulled reported EBITDA down to EUR 316.4 million, and non-cash impairments of EUR 136.1 million tied to the Heiligenkreuz and Grimsby sites deepened the damage. The net result was a loss of EUR 130.3 million, wider than the EUR 105 million shortfall posted a year earlier.

The gap between the adjusted and reported figures is where the story of the turnaround sits. The first set shows how the business performs absent one-off items; the second shows what the reorganisation actually costs on the balance sheet. Lenzing is also cutting roughly 600 jobs, halting production at Heiligenkreuz by the end of the first quarter of 2027 and ending output at Grimsby by the close of that year.

Strategically, the group wants to lean into nonwovens and shift its textile fibres toward premium and specialty grades, retreating from low-margin standard fibres that have weighed on profitability. Management has set its sights on an EBITDA improvement of EUR 150 million over the medium term, a margin of 20–25% and a leverage ratio below 2.5 — targets that describe the ambition rather than the current reality.

Savings Target Reaffirmed

Underpinning all of it is a pledge to strip out an additional EUR 120 million in costs by the end of 2027, measured against a 2025 cost base. The company reiterated that goal on Thursday. Whether the operational stabilisation now visible in the accounts can harden into a durable recovery is the question investors must weigh, and the savings programme alone does not settle it.

Cash generation offers a sobering counterpoint. Free cash flow came in at EUR 24.7 million, down sharply from EUR 110.9 million a year earlier, while net financial debt stood at EUR 1,418.9 million at the end of the reporting period.

Balance Sheet Gets a Refill

Lenzing moved to shore up its finances before those numbers landed. A capital increase that took effect roughly two weeks ago raised about EUR 300 million, and the company has lined up further financing agreements worth another EUR 300 million. Around half of that second tranche is already contractually secured, with completion targeted for the end of 2026.

Ownership has shifted modestly in step with the cash call. According to stake disclosures dated 29 October, the syndicate of B&C Group and Suzano S.A. continues to hold roughly 52.25% of voting rights, while Suzano Holding S.A. picked up about 0.80% of Lenzing shares directly in connection with the capital increase. Goldman Sachs Group held 5.86%.

For the full year, Lenzing expects adjusted EBITDA of EUR 430 million to EUR 460 million. Hitting that range — and converting it into stronger free cash flow — is the test that will determine whether the cost programme and the fresh equity translate into a genuinely repaired balance sheet, or merely buy time.